Sybleu

Sybleu is a biotechnology company engaged in the development of regenerative medical applications. Currently, the company is developing a patented cancer treatment method, which involves the simultaneous injection of chemotherapeutic drugs and immune modulators in sustained-release formulations directly into the tumor.